These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 12691786

  • 1. Sertraline is more effective than imipramine in the treatment of non-melancholic depression: results from a multicentre, randomized study.
    Baca E, González de Chávez M, García-Toro M, Pérez-Arnau F, Porras-Chavarino A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):493-500. PubMed ID: 12691786
    [Abstract] [Full Text] [Related]

  • 2. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E, Garcia-Garcia M, Porras-Chavarino A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [Abstract] [Full Text] [Related]

  • 3. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C, Olivieri L, Di Loreto G, Dionisio P.
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [Abstract] [Full Text] [Related]

  • 4. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE, Franznick DA, Hollander SB, Fava M.
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 7. Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder.
    Steiner M, Allgulander C, Ravindran A, Kosar H, Burt T, Austin C.
    Hum Psychopharmacol; 2005 Jan; 20(1):3-13. PubMed ID: 15551351
    [Abstract] [Full Text] [Related]

  • 8. Predictors of an acute antidepressant response to fluoxetine and sertraline.
    Flament MF, Lane RM, Zhu R, Ying Z.
    Int Clin Psychopharmacol; 1999 Sep; 14(5):259-75. PubMed ID: 10529069
    [Abstract] [Full Text] [Related]

  • 9. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 10. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [Abstract] [Full Text] [Related]

  • 12. Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
    Thase ME, Rush AJ, Howland RH, Kornstein SG, Kocsis JH, Gelenberg AJ, Schatzberg AF, Koran LM, Keller MB, Russell JM, Hirschfeld RM, LaVange LM, Klein DN, Fawcett J, Harrison W.
    Arch Gen Psychiatry; 2002 Mar; 59(3):233-9. PubMed ID: 11879161
    [Abstract] [Full Text] [Related]

  • 13. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
    Cohn CK, Shrivastava R, Mendels J, Cohn JB, Fabre LF, Claghorn JL, Dessain EC, Itil TM, Lautin A.
    J Clin Psychiatry; 1990 Dec; 51 Suppl B():28-33. PubMed ID: 2258379
    [Abstract] [Full Text] [Related]

  • 14. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
    Licht RW, Qvitzau S.
    Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594
    [Abstract] [Full Text] [Related]

  • 15. Double-blind, multicenter comparative study of sertraline versus amitriptyline in outpatients with major depression.
    Möller HJ, Glaser K, Leverkus F, Göbel C.
    Pharmacopsychiatry; 2000 Nov; 33(6):206-12. PubMed ID: 11147927
    [Abstract] [Full Text] [Related]

  • 16. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH, Watkin JG, Liu C, Wohlreich MM, Raskin J.
    BMC Psychiatry; 2005 Jan 04; 5():1. PubMed ID: 15631624
    [Abstract] [Full Text] [Related]

  • 17. A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
    Fava M, Nierenberg AA, Quitkin FM, Zisook S, Pearlstein T, Stone A, Rosenbaum JF.
    Psychopharmacol Bull; 1997 Jan 04; 33(1):101-3. PubMed ID: 9133758
    [Abstract] [Full Text] [Related]

  • 18. A double-blind comparison of gepirone extended release, imipramine, and placebo in the treatment of outpatient major depression.
    Feiger AD.
    Psychopharmacol Bull; 1996 Jan 04; 32(4):659-65. PubMed ID: 8993088
    [Abstract] [Full Text] [Related]

  • 19. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
    Brady KT, Clary CM.
    Compr Psychiatry; 2003 Jan 04; 44(5):360-9. PubMed ID: 14505296
    [Abstract] [Full Text] [Related]

  • 20. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
    McRae AL, Brady KT, Mellman TA, Sonne SC, Killeen TK, Timmerman MA, Bayles-Dazet W.
    Depress Anxiety; 2004 Jan 04; 19(3):190-6. PubMed ID: 15129422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.